Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: June 19, 2013

Drug Name	Review Type	Class	Manufacturer
Invokana	New Drug Initial Review	SGLT2 Inhibitor	Janssen
Pertzye	New Drug Initial Review	Pancreatic Enzyme	Digestive Care, Inc
Vascepa	New Drug Initial Review	Lipotropic	Amarin
Myrbetriq	New Drug Initial Review	Urinary Anti-Incontinence Agent	Astellas Pharma
Tecfidera	New Drug Initial Review	Multiple Sclerosis	Biogen Idec
Nesina	New Drug Initial Review	DPP-4 Inhibitor	Takeda
Diclegis	New Drug Initial Review	Antiemetic	Duchesnay USA
Tradjenta	New Drug Appeal	DPP-4 Inhibitor	Boehringer-Ingelheim
Tudorza Pressair	New Drug Appeal	Long Acting Anticholingergic	Forest
Stribild	New Drug Appeal	HIV/AIDS	Gilead
Humatrope	PDL Appeal	Growth Hormone	Eli Lilly